MYX mayne pharma group limited

3.27%

$5.03

I tend to think the share price action is a decent gauge of...

First 479 Last

Share
Profile

Follow
Dabble010

4,912 Posts.

1593

15/11/24

09:37

Post #: 76618644
Share

Originally posted by Hadrian: ↑

Hey Dickkyboy,

Looking at the argument you've presented objectively, I can't say that I disagree with much of what you've written. Perhaps you picked up the eventual flattening of Nextstellis earlier than I did. Back in 2022-23 they reported script sales on a monthly basis and these were quite volatile, the November, December January growth were +5%,-5% and 10.5% before that there were also negative figures and high teens but here we are again where the two quarterly figures reported hence are +5.9% QoQ or +1.8% MoM for 3QFY or +10.4%QoQ or +3.4% MoM for 4QFY, we will know next week what the trajectory is for the last 4 months.

Just as a sober comparison, Gedeon Richter reported their 3Q performance a few days ago and reported Drovelis sales grew 52% YoY which is about 3.3% MoM so they're also not growing market share any quicker than what we are and just maybe that is the growth rate we should expect and not the 9% seen in 2022-23. Even so, with 3.4% MoM growth we will have a profitable product it will just take longer.

I also don't disagree with your assessment of the TherepeuticsMD products, we were slow off the mark marketing these products in the first few months and the last few months, I have interpreted as growth and you as back to normal both interpretations are possible once again we will know more next week.

I will add one more comment which tilts my belief more to the growth side and that is that the CEO was aware of the slow down by Xmas last year when he began to restructure the WH sales team, this new team and leadership has now been in place for a few months and just maybe the turnaround in the last quarter is a sign of improvement and not just volatility of the figures.

Expand

I tend to think the share price action is a decent gauge of performance and the fact that this had fizzled despite rumours in AFR etc gives me a hint things aren't all that well!

but I got out and got back in and now can't be bothered doing anything more about this. If it goes to zero, it will just have to be a capital loss I take on the chin!

MYX Price at posting: $4.88 Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

PIQ

Proteomics notches up as company launches PromarkerD into the US

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

PV1

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

AL3

AML3D opens new facility in Ohio as US Defence strategy bears fruit

NVO

Novo flags antimony and gold in the Pilbara – but does it need to step back?

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

First 479 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $5.03		Change -0.170(3.27%)		Mkt cap ! $408.6M

Open	High	Low	Value	Volume
$5.20	$5.21	$5.03	$2.804M	555.6K

Buyers (Bids)

No.	Vol.	Price($)
2	14654	$5.03

Sellers (Offers)

Price($)	Vol.	No.
$5.14	3111	2

View Market Depth

No.	Vol.	Price($)
1	1000	5.010
2	61000	5.000
2	2200	4.990
2	702	4.970
3	2200	4.950

Price($)	Vol.	No.
5.140	3111	2
5.150	19052	1
5.180	396	1
5.200	2000	1
5.300	10000	1

Last trade - 16.10pm 20/06/2025 (20 minute delay)

MYX (ASX) Chart

I tend to think the share price action is a decent gauge of...

Proteomics notches up as company launches PromarkerD into the US

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

AML3D opens new facility in Ohio as US Defence strategy bears fruit

Novo flags antimony and gold in the Pilbara – but does it need to step back?

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

I tend to think the share price action is a decent gauge of...

Top Stories

Proteomics notches up as company launches PromarkerD into the US

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

AML3D opens new facility in Ohio as US Defence strategy bears fruit

Novo flags antimony and gold in the Pilbara – but does it need to step back?

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News